Values First Advisors Inc. Sells 6,382 Shares of Elanco Animal Health Incorporated (NYSE:ELAN)

Values First Advisors Inc. trimmed its holdings in Elanco Animal Health Incorporated (NYSE:ELAN) by 18.3% in the 4th quarter, according to its most recent filing with the SEC. The institutional investor owned 28,498 shares of the company’s stock after selling 6,382 shares during the quarter. Values First Advisors Inc.’s holdings in Elanco Animal Health were worth $345,000 at the end of the most recent reporting period.

Other large investors also recently bought and sold shares of the company. ORG Wealth Partners LLC purchased a new stake in shares of Elanco Animal Health during the 3rd quarter valued at about $29,000. AM Squared Ltd purchased a new position in shares of Elanco Animal Health during the third quarter valued at approximately $34,000. Wilmington Savings Fund Society FSB bought a new position in Elanco Animal Health during the third quarter valued at approximately $35,000. Farther Finance Advisors LLC boosted its holdings in Elanco Animal Health by 158.7% in the third quarter. Farther Finance Advisors LLC now owns 3,332 shares of the company’s stock worth $49,000 after purchasing an additional 2,044 shares during the last quarter. Finally, Venturi Wealth Management LLC grew its position in Elanco Animal Health by 89.9% in the 3rd quarter. Venturi Wealth Management LLC now owns 3,382 shares of the company’s stock worth $50,000 after purchasing an additional 1,601 shares during the period. 97.48% of the stock is currently owned by institutional investors.

Analysts Set New Price Targets

Several equities analysts have recently weighed in on the company. Leerink Partnrs raised Elanco Animal Health to a “hold” rating in a report on Monday, December 2nd. Leerink Partners started coverage on Elanco Animal Health in a report on Monday, December 2nd. They issued a “market perform” rating and a $14.00 target price on the stock. Morgan Stanley dropped their target price on Elanco Animal Health from $15.00 to $14.00 and set an “equal weight” rating on the stock in a research report on Wednesday, January 29th. UBS Group began coverage on shares of Elanco Animal Health in a research report on Monday, December 9th. They set a “buy” rating and a $18.00 price target for the company. Finally, Stifel Nicolaus dropped their price objective on shares of Elanco Animal Health from $20.00 to $18.00 and set a “buy” rating on the stock in a report on Tuesday, January 7th. One research analyst has rated the stock with a sell rating, four have issued a hold rating and three have issued a buy rating to the company’s stock. According to MarketBeat.com, the company currently has a consensus rating of “Hold” and an average price target of $16.29.

Elanco Animal Health Stock Performance

Shares of ELAN opened at $11.38 on Thursday. The business has a 50-day simple moving average of $11.97 and a two-hundred day simple moving average of $13.17. The company has a quick ratio of 1.31, a current ratio of 2.55 and a debt-to-equity ratio of 0.66. Elanco Animal Health Incorporated has a 52 week low of $11.11 and a 52 week high of $18.80. The stock has a market cap of $5.63 billion, a price-to-earnings ratio of 28.45, a PEG ratio of 2.69 and a beta of 1.42.

About Elanco Animal Health

Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals. It offers pet health disease prevention products, such as parasiticide and vaccine products that protect pets from worms, fleas, and ticks under the Seresto, Advantage, Advantix, and Advocate brands; pet health therapeutics for pain, osteoarthritis, ear infections, cardiovascular, and dermatology indications in canines and felines under the Galliprant and Claro brands; vaccines, antibiotics, parasiticides, and other products for use in poultry and aquaculture production, as well as nutritional health products, including enzymes, probiotics, and prebiotics; and a range of vaccines, antibiotics, implants, parasiticides, and other products used in ruminant and swine production under the Rumensin and Baytril brands.